- Home
- VTVT vs EDAP Comparison
VTVT vs EDAP Comparison
Compare VTVT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- EDAP
- Stock Information
- Founded
- VTVT 2015
- EDAP 1979
- Country
- VTVT United States
- EDAP France
- Employees
- VTVT N/A
- EDAP N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VTVT Health Care
- EDAP Health Care
- Exchange
- VTVT Nasdaq
- EDAP Nasdaq
- Market Cap
- VTVT 56.7M
- EDAP 53.8M
- IPO Year
- VTVT 2015
- EDAP 1997
- Fundamental
- Price
- VTVT $16.67
- EDAP $1.81
- Analyst Decision
- VTVT Strong Buy
- EDAP Buy
- Analyst Count
- VTVT 2
- EDAP 3
- Target Price
- VTVT $35.50
- EDAP $8.50
- AVG Volume (30 Days)
- VTVT 5.3K
- EDAP 54.3K
- Earning Date
- VTVT 05-15-2025
- EDAP 05-15-2025
- Dividend Yield
- VTVT N/A
- EDAP N/A
- EPS Growth
- VTVT N/A
- EDAP N/A
- EPS
- VTVT N/A
- EDAP N/A
- Revenue
- VTVT $17,000.00
- EDAP $67,840,467.00
- Revenue This Year
- VTVT N/A
- EDAP N/A
- Revenue Next Year
- VTVT N/A
- EDAP N/A
- P/E Ratio
- VTVT N/A
- EDAP N/A
- Revenue Growth
- VTVT N/A
- EDAP 3.69
- 52 Week Low
- VTVT $12.12
- EDAP $1.26
- 52 Week High
- VTVT $26.99
- EDAP $5.46
- Technical
- Relative Strength Index (RSI)
- VTVT 40.48
- EDAP 45.48
- Support Level
- VTVT $15.92
- EDAP $1.75
- Resistance Level
- VTVT $16.70
- EDAP $1.89
- Average True Range (ATR)
- VTVT 0.98
- EDAP 0.13
- MACD
- VTVT -0.37
- EDAP -0.01
- Stochastic Oscillator
- VTVT 16.47
- EDAP 64.71
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.